FDA approves daily pill to treat low libido in women after menopause: What to know
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin)Trusted Source for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.
Read More
Zimbabwean Innovators Win Cimas Healthathon with Epilepsy Monitoring App
By Michael Gwarisa Two young Zimbabweans have embarked on a mission to transform the nation’s healthcare landscape with a new digital tool, the Epi App. The innovation aims to provide real-time monitoring for epilepsy patients, potentially reducing the life-altering risks associated with the disorder. The mobile application, developed by Munashe Dube, a Bioengineering student at the
Read More
Zimbabwe Medical Doctor Launches ColpoPen, An AI Tool To Screen Cervical Cancer
By Michael Gwarisa Zimbabwe continues to lose over 1,000 women to cervical cancer annually, with data showing that an estimated 3,043 women are diagnosed with the disease each year. Despite this grim reality, access to screening services for women in Zimbabwe remains a challenge due to a myriad of factors, including lack of knowledge and awareness,
Read More
Cimas MEDLABS introduces advanced genetic testing services
By Staff Reporter THE country’s top provider of diagnostic and medical laboratory services, Cimas Medlabs has added the advanced genetic testing service on its procedures marking a significant milestone in the provision of cutting-edge healthcare solutions in Zimbabwe. As one of the leading medical laboratories in the country, Cimas Medlabs provides a wide range of pathology
Read More
Why Africans and Europeans React To Medicines Differently: Zimbabwean Scientist Tests Effectiveness of Pharmacogenetics in African Populations
While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the field
Read More
New CIMAS Gene Sequencing Technology To Revolutionize Early Detection Of Cancer and Lifestyle Diseases In Zimbabwe
By Michael Gwarisa In a bid to improve detection and treatment of Non-Communicable Diseases (NCDs) and other lifestyle diseases in Zimbabwe, CIMAS Medical Aid Society has procured a Genetic Sequencing device that is set to be a game changer in Zimbabwe’s public health system. The Gene Sequencer is a fairly new technology in Zimbabwe, with CIMAS’s laboratory division
Read More
Cimas MEDLABS Retools laboratories To Enhance Results Turnaround Time
THE country’s top provider of diagnostic and medical laboratory services, Cimas MEDLABS has embarked on a project to renovate and re-equip its laboratories to ensure that tests are offered onsite in a bid to provide timely results across the country. Cimas MEDLABS is a designated Health Institution by the Medical Laboratory and Clinical Scientists Association of Zimbabwe that
Read More
Africa CDC Establishes Platform To Boost Manufacturing Of Vaccines, Therapeutics and Diagnostics in Africa
By Michael Gwarisa The Africa Centres for Diseases Control (Africa CDC), has established a new system, the Platform for Harmonised Africa Health Products Manufacturing (PHAHP), that will see the continent coordinating the manufacturing of vaccines, therapeutics and diagnostics, a top Africa CDC official has said. While the continent has already made inroads regarding local manufacturing of
Read More
Zimbabwe To Manufacture Praziquantel For Schistosomiasis Treatment
By Michael Gwarisa A Memorandum of Understanding (MoU) signed between the Ministry of Health and Child Care (MoHCC) and the China National Institute of Parasitic Diseases (NIPD), will see Zimbabwe becoming a manufacturing powerhouse for Praziquantel, a drug used to treat Schistosomiasis, also known as snail fever or bilharzia. This comes after Zimbabwe was selected to
Read More
Say Good Bye To Fake COVID-19 Certificates Headache, CIMAS QR CODE Is The Real Deal
IMAGINE getting to Robert Mugabe International Airport (formerly Harare Int Airport), bags packed and ready to travel only to be told that your COVID-19 test certificate is invalid and you can’t go beyond the security checkpoint. Heart rending, isn’t it? The golden rule of thumb is never to do shortcuts and use reputable COVID-19 testing centers
Read More